BREAKING
AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 18 minutes ago Best Buy 1Q 2026: Profitability Surges Despite Revenue Dip 4 hours ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago AutoZone (AZO) Q2 2026 earnings decline despite 8% sales growth 18 minutes ago Best Buy 1Q 2026: Profitability Surges Despite Revenue Dip 4 hours ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago
ADVERTISEMENT
Market News

Vertex Pharma Q3 2023 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is scheduled to publish earnings for the third quarter of 2023, today at 4:00 p.m. ET. Listen to Vertex Pharmaceuticals‘ Q3 2023 earnings call live and read the real-time transcript Analysts following the company are looking for September-quarter profit, adjusted for special items, of $3.98 per share, vs. […]

November 6, 2023 1 min read

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is scheduled to publish earnings for the third quarter of 2023, today at 4:00 p.m. ET. Listen to Vertex Pharmaceuticals‘ Q3 2023 earnings call live and read the real-time transcript Analysts following the company are looking for September-quarter profit, adjusted for special items, of $3.98 per share, vs. […]

· November 6, 2023

Healthcare firm Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is scheduled to publish earnings for the third quarter of 2023, today at 4:00 p.m. ET.

Listen to Vertex Pharmaceuticals Q3 2023 earnings call live and read the real-time transcript



Analysts following the company are looking for September-quarter profit, adjusted for special items, of $3.98 per share, vs. $4.01 per share in the corresponding period of 2022. They also predict a 12% increase in Q3 revenues to around $2.5 billion.

In the second quarter, revenues increased 14% year-over-year to $2.49 billion. Adjusted earnings moved up to $3.89 per share from $3.60 per share in Q3 2022. Unadjusted profit was $915.7 million or $3.52 per share in the March quarter, compared to $810.5 million or $3.13 per share last year.

ADVERTISEMENT